Select a region
Jersey’s cannabis industry has yet to generate substantial tax revenue due to “high upfront costs”, the Treasury Minister has said.
Speaking at yesterday’s States Assembly sitting, Deputy Elaine Millar outlined the challenges faced by the new and developing cannabis sector and defended the current tax framework in response to questions from Deputy Philip Ozouf.
She said: “The Government and Revenue Jersey are monitoring this nascent industry closely to ensure that tax treatment of its profits and gains remains appropriate.”
Deputy Millar continued: "In line with this, fewer than 12 companies who identified they received income in 2022 as a licensed cannabis cultivator had a positive tax liability for that year.
“As a matter of policy, the controller will not specify numbers of taxpayers below 12, nor the amounts payable at this stage to avoid inadvertent breaches of taxpayer confidentiality.
“As we have only received one year of tax returns from this industry, it would be premature to review the tax regime at this stage.”
The Treasury Minister also explained that cannabis businesses involved in cultivation, processing, or distribution are taxed at 20%, while dispensaries operating as retailers fall under Jersey’s 0% corporate tax regime.
General practitioners, who issue prescriptions, are taxed individually on their profits.
This discussion comes against a backdrop of stalled strategic development for Jersey’s cannabis sector, after then-Economic Development Minister Minister Lyndon Farnham told a Toronto conference of Jersey’s vision to sit at the “forefront of the emerging European cannabis market” back in 2019.
Despite earlier ambitions to position the island as a leader in the European cannabis market, resource constraints halted the creation of a dedicated industry strategy in September.
Since 2019, over £100,000 has been spent on consultancy services and regulatory support, but the Minister said last year that the cannabis industry had brought up to £60m of inward investment into Jersey.
£100,000s spent… but cannabis industry strategy sidelined
Medicinal cannabis industry brings up to £60m investment to Jersey
Politicians “extremely concerned” by lack of medicinal cannabis regulation
FOCUS: A blossoming $600m opportunity at risk
Comments
Comments on this story express the views of the commentator only, not Bailiwick Publishing. We are unable to guarantee the accuracy of any of those comments.